Takip et
Jagpreet singh nanda
Jagpreet singh nanda
Project scientist (Cedars Sinai Medical Center)
cshs.org üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Topical delivery of protein and peptide using novel cell penetrating peptide IMT-P8
A Gautam, JS Nanda, JS Samuel, M Kumari, P Priyanka, G Bedi, SK Nath, ...
Scientific reports 6 (1), 26278, 2016
752016
Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine
S Gupta, K Chaudhary, R Kumar, A Gautam, JS Nanda, SK Dhanda, ...
Scientific reports 6 (1), 23857, 2016
712016
dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes
J Singh Nanda, R Kumar, GPS Raghava
Scientific reports 6 (1), 19340, 2016
642016
Role of Swi6/HP1 self-association-mediated recruitment of Clr4/Suv39 in establishment and maintenance of heterochromatin in fission yeast
S Haldar, A Saini, JS Nanda, S Saini, J Singh
Journal of biological chemistry 286 (11), 9308-9320, 2011
562011
Ablation of RNA interference and retrotransposons accompany acquisition and evolution of transposases to heterochromatin protein CENPB
U Upadhyay, S Srivastava, I Khatri, JS Nanda, S Subramanian, A Arora, ...
Molecular biology of the cell 28 (8), 1132-1146, 2017
232017
Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro
SE Kohrt, WN Awadallah, RA Phillips III, TC Case, R Jin, JS Nanda, X Yu, ...
Molecular cancer therapeutics 20 (2), 398-409, 2021
202021
Increased nuclear factor I/B expression in prostate cancer correlates with AR expression
JS Nanda, WN Awadallah, SE Kohrt, P Popovics, JMM Cates, ...
The Prostate 80 (13), 1058-1070, 2020
92020
Role of Cdc23/Mcm10 in generating the ribonucleotide imprint at the mat1 locus in fission yeast
B Singh, KK Bisht, U Upadhyay, AC Kushwaha, JS Nanda, S Srivastava, ...
Nucleic acids research 47 (7), 3422-3433, 2019
92019
Phenotypic plasticity-alternate transcriptional programs driving treatment resistant prostate cancer
JS Nanda, P Koganti, G Perri, L Ellis
Critical Reviews™ in Oncogenesis 27 (1), 2022
32022
An RNAi-independent role of AP1-like stress response factor Pap1 in centromere and mating-type silencing in Schizosaccaromyces pombe
A Kumar, JS Nanda, S Saini, J Singh
Journal of Biosciences 46, 1-14, 2021
22021
Nuclear factor I/B increases in prostate cancer to support androgen receptor activation
JS Nanda, WN Awadallah, SE Kohrt, P Popovics, JM Cates, J Mirosevich, ...
BioRxiv: Jun 27, 2019
22019
Cdc23/Mcm10 Primase Generates the Lagging Strand-Specific Ribonucleotide Imprint in Fission Yeast
B Singh, KK Bisht, U Upadhyay, AC Kushwaha, JS Nanda, S Srivastava, ...
bioRxiv, 303180, 2018
12018
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer
B German, JN Singh, MAS Fonseca, DL Burkhart, A Sheahan, H Bergom, ...
bioRxiv, 2024
2024
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer
LE Beatriz German, Jagpreet Singh Nanda, Marcos Ads Fonseca, Deborah L ...
biorxiv, 2024
2024
Loss of tristetraprolin activates NF-κB induced phenotypic plasticity and primes transition to lethal prostate cancer
KL Morel, AA Hamid, BG Falcón, JS Nanda, S Linder, AM Bergman, ...
bioRxiv, 2022.08. 05.500896, 2022
2022
IL1B loss is associated with increased AR activity in castration-resistant prostate cancer
WN Awadallah, JS Nanda, SE Kohrt, MM Grabowska
bioRxiv, 2021.08. 31.458406, 2021
2021
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–16